The efficacy and safety of oral anticoagulants in warfarin-suitable patients with nonvalvular atrial fibrillation: systematic review and meta-analysis.
about
New oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney diseaseSurgery for atrial fibrillationNovel oral anticoagulants in non-valvular atrial fibrillation.Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care.NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysisCost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.Stroke and systemic embolism prevention in patients with atrial fibrillation in Belgium: comparative cost effectiveness of new oral anticoagulants and warfarin.Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.Anticoagulation Control in Swiss Primary Care: Time in Therapeutic Range Percentages Exceed Benchmarks of Phase III Trials.Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis.Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: A view from the Middle East and North Africa.
P2860
Q24192938-3C502CF1-B8E6-4BE2-84EE-CCFDBE8743D0Q27022070-B01F4A34-282F-4091-A915-8098645CDFDAQ34666804-B1C62A6A-8B38-4DE7-B7C2-D712BA35ADDBQ37312543-3A453DD7-88E3-4AFA-9F0F-DDB5964E05BAQ38723893-6912D755-87FC-418B-A25C-416F88A3CE6AQ40523358-5AFFE8D3-91FF-4F2C-A662-8E3A63212D81Q41685690-E031D68B-9916-46A5-85CE-CC8E64707FD9Q47654635-430316B6-660A-4242-8B00-6E11C5FCCFEAQ47713063-363C692E-B747-4C59-A1E1-FB6F888CFDC6Q49499951-625A8E08-D25B-4B8F-BA97-27AB50B7BA6FQ55032516-7DF11F9E-D9AC-421E-A24D-62530CDA394AQ55222788-43135E16-D268-4D67-8E27-B1BA72424B57
P2860
The efficacy and safety of oral anticoagulants in warfarin-suitable patients with nonvalvular atrial fibrillation: systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The efficacy and safety of ora ...... atic review and meta-analysis.
@en
type
label
The efficacy and safety of ora ...... atic review and meta-analysis.
@en
prefLabel
The efficacy and safety of ora ...... atic review and meta-analysis.
@en
P2093
P2860
P356
P1476
The efficacy and safety of ora ...... matic review and meta-analysis
@en
P2093
David Jakouloff
Ian Lockhart
Michelle E Orme
Pieter Drost
Stephen A Mitchell
Teresa A Simon
P2860
P304
P356
10.1177/1076029613486539
P50
P577
2013-05-22T00:00:00Z